Fujifilm Holdings’ stock jumped on 27 October after the Japanese firm said it will buy 49% of US-based Kalon Biotherapeutics, a maker of vaccines used against pandemic influenza, Ebola and other public health threats.
Fujifilm’s stock finished 2.89% higher in Tokyo on the news, while the benchmark Nikkei 225 share average closed 0.63% higher.
Fujifilm, in a statement, also said that its US unit, Fujifilm Diosynth Biotechnologies, may increase the stake to 100% after the initial purchase based on the achievement of certain milestones.
The purchase amount was not revealed.
The post Fujifilm to Buy Stake in US Vaccine Maker Kalon Biotherapeutics as Ebola Spreads appeared first on Trunews:.
from Trunews: http://ift.tt/1wGY6q4
via IFTTT
No comments:
Post a Comment